News
MIRA Pharmaceuticals (MIRA) announced the acceptance of a second peer-reviewed manuscript describing its lead oral drug candidate, Ketamir-2, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback